Product
Tigulixostat
Aliases
LC350189
3 clinical trials
3 indications
Indication
GoutIndication
HyperuricemiaIndication
Gout FlareClinical trial
A Phase 1, Open-Label, Drug-Drug Interaction Study to Evaluate the Effect of Multiple Oral Doses of Tigulixostat on the Pharmacokinetics of a Single Oral Dose of TheophyllineStatus: Completed, Estimated PCD: 2023-11-13
Clinical trial
A Randomized, Multi-regional, Double-blind, Parallel-group, Placebo-controlled Phase 3 Study to Assess the Safety and Efficacy of 6 Months Treatment With Tigulixostat in Gout Patients With HyperuricemiaStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Randomized, Multi-regional, Double-blind, Double-dummy Parallel-group, Placebo and Allopurinol-controlled Phase 3 Study to Assess the Efficacy and Safety of Tigulixostat in Gout Patients With HyperuricemiaStatus: Recruiting, Estimated PCD: 2025-07-01